HS3ST2 modulates breast cancer cell invasiveness via MAP kinase-and Tcf4 (Tcf7l2)-dependent regulation of protease and cadherin expression

Kumar A., Gassar E., Spillmann D., Stock C., Sen Y., Zhang T., Van Kuppevelt T., Hulsewig C., Kozlowski E., Pavao M., Ibrahim S., Poeter M., Rescher U., Kiesel L., Koduru S., Yip G., Gotte M.

Forschungsartikel (Zeitschrift) | Peer reviewed

Zusammenfassung

Heparan sulfate 3-O-sulfotransferase 2 (HS3ST2), an enzyme mediating 3-O-sulfation of heparan sulfate (HS), is silenced by hypermethylation in breast cancer. As HS has an important co-receptor function for numerous signal transduction pathways, the phenotypical changes due to HS3ST2 reexpression were investigated in vitro using high and low invasive breast cancer cell lines. Compared to controls, highly invasive HS3ST2-expressing MDA-MB-231 cells showed enhanced Matrigel invasiveness, transendothelial migration and motility. Affymetrix screening and confirmatory real-time PCR and Western blotting analysis revealed increased expression of several matrix metalloproteinases, cadherin-11, E-cadherin and CEACAM-1, while protease inhibitor and annexin A10 expression were decreased. Low invasive HS3ST2-expressing MCF-7 cells became even less invasive, with no change in gelatinolytic MMP activity. HS3ST2 expression increased HS-dependent basal and FGF2-specific signaling through the constitutively active p44/42 MAPK pathway in MDA-MB-231 cells. Increased MAPK activation was accompanied by upregulation of ß-catenin in MDA-MB-231, and of the transcription factor Tcf4 in both cell lines. Dysregulation of Tcf4-regulated ion transporters and increased cytosolic acidification were observed in HS3ST2-expressing MDA-MB-231 cells, which is a possible underlying cause of increased chemosensitivity towards doxorubicine and paclitaxel in these cells. This study provides the first in vitro evidence of the involvement of HS3ST2 in breast cancer cell invasion and chemosensitivity.

Details zur Publikation

FachzeitschriftInternational Journal of Cancer (Int J Cancer)
Jahrgang / Bandnr. / Volume135
Ausgabe / Heftnr. / Issue11
Seitenbereich2579-2592
StatusVeröffentlicht
Veröffentlichungsjahr2014
Sprache, in der die Publikation verfasst istEnglisch
DOI10.1002/ijc.28921
Link zum Volltexthttp://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84910110007&origin=inward
StichwörterCadherin; Chemosensitivity; Glycosaminoglycan; Heparan sulfate; Invasiveness; Metastasis; Signal transduction

Autor*innen der Universität Münster

Götte, Martin
Klinik für Frauenheilkunde und Geburtshilfe

Preisverleihungen erhalten für die Publikation

ISGE-Nachwuchspreis/Kongressstipendium
Verliehen von: Internationale Gesellschaft für Gynäkologische Endokrinologie (ISGE)
Verliehen an: Vijaya Kumar, Archana; Götte, Martin
Verleihung erfolgte am: 15.03.2014
Art der Preisverleihung: Forschungspreis oder andere Auszeichnung

Vorträge zur Publikation

HS3ST2 modulates breast cancer cell invasiveness via MAP kinase- and Tcf4-dependent regulation of protease and cadherin expression.
Martin Götte (11.11.2013)
Novel Insights into Cancer Biology: New Targets and Therapeutic Approaches, Kairo, Ägypten
Art des Vortrags: wissenschaftlicher Vortrag

Promotionen, aus denen die Publikation resultiert

The role of heparan sulfate 3-O- and 2-O-sulfation in breast cancer pathogenesis
Promovend*in: Vijaya Kumar, Archana | Betreuer*innen: Götte, Martin; Moerschbacher, Bruno
Zeitraum: 01.04.2011 - 01.07.2014
Promotionsverfahren erfolgt(e) an: Promotionsverfahren an der Universität Münster
Role of the heparan sulfate sulfotransferase HS3ST2 in breast cancer cell motility and invasiveness
Promovend*in: Gassar, Ezeddin Salem | Betreuer*innen: Götte, Martin; Stock, Christian; Kiesel, Ludwig
Zeitraum: bis 01.04.2011
Promotionsverfahren erfolgt(e) an: Promotionsverfahren an der Universität Münster